Nanomedicine targeting brain lipid metabolism as a feasible approach for controlling the energy balance

This project was financially supported by the Joint Bilateral Project Japan-Spain (PCI2018-092997 to R. R.-R.)/Agencia Estatal de Investigación (AEI) and (20jm0210059h0003 to S.Q.)/Agency for Medical Research and Development (AMED), the Japan Society for Promotion of Science (JSPS) Bilateral Joint R...

Descripción completa

Detalles Bibliográficos
Autores: García-Chica, Jesús, Paraiso, West Kristian, Zagmutt, Sebastián, Fosch, Anna, Reguera, Ana Cristina, Alzina, Sara, Sánchez-García, Laura, Fukushima, Shigeto, Toh, Kazuko, Casals, Núria, Serra, Dolors, Herrero, Laura, Garcia Gomez, Jordi, Kataoka, Kazunori, Ariza, Xavier, Quader, Sabina, Rodriguez-Rodriguez, Rosalia
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:20.500.12328/3633
Acceso en línea:http://hdl.handle.net/20.500.12328/3633
https://dx.doi.org/10.1039/D2BM01751B
Access Level:acceso abierto
Palabra clave:Metabolisme
Fàrmacs
Metabolismo
Fármacos
Metabolism
Drugs
615
Descripción
Sumario:This project was financially supported by the Joint Bilateral Project Japan-Spain (PCI2018-092997 to R. R.-R.)/Agencia Estatal de Investigación (AEI) and (20jm0210059h0003 to S.Q.)/Agency for Medical Research and Development (AMED), the Japan Society for Promotion of Science (JSPS) Bilateral Joint Research Projects (JPJSBP120209938 to S. Q.), and the Center of Innovation (COI) Program (JPMJCE1305) from Japan Science and Technology Agency (JST). This study was also supported by the Ministerio de Ciencia e Innovación (MCIN/AEI/10.13039/501100011033) (PID2020-114953RB-C22 to N. C. and R. R.-R.; PID2020-114953RB-C21 to L. H. and D. S.) co-funded by the European Regional Development Fund [ERDF], the Biomedical Research Centre in Pathophysiology of Obesity and Nutrition (CIBEROBN) (grant CB06/03/0001 to L. H.), and the Merck Health Foundation (to L. H.).